✦ LIBER ✦

A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion

✍ Scribed by Reid, A G; Nacheva, E P

Book ID: 110055690
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 123 KB
Volume: 18
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403162

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MicroRNAs and deletion of the derivative

MicroRNAs and deletion of the derivative chromosome 9 in chronic myeloid leukemia

✍ Chaubey, A; Karanti, S; Rai, D; Oh, T; Adhvaryu, S G; Aguiar, R C T 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 144 KB

Genesis of derivative chromosome 9 delet

Genesis of derivative chromosome 9 deletions in chronic myeloid leukemia. Reply to the comment by A.G. Reid and E.P. Nacheva

✍ Dong Soon Lee 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

A study on the incidence of ABL gene del

A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression

✍ Dong Soon Lee; Yun-Song Lee; Yeon-sook Yun; Young-Ree Kim; Seok San Jeong; Young 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

## Abstract Fluorescence in situ hybridization for the __BCR__/__ABL__ rearrangement in 138 bone marrow specimens from 59 Philadelphia^+^ (Ph^+^) chronic myelogenous leukemia (CML) patients, 35 Ph^+^ acute lymphoblastic leukemia (ALL) patients, and 57 Ph^−^ ALL patients was used. Sixteen (27.1%) of

No significance of derivative chromosome

No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia

✍ Dong Hwan (Dennis) Kim; Gizelle Popradi; Lakshmi Sriharsha; Suzanne Kamel-Reid; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB